Vireo Growth VREOF
OTC VREOF
$10.97 -0.01 (-0.09%)
At close: Aug 19, 2026 · 3:35 PM UTC

Vireo Growth (VREOF) Cash & Current Investments (2020 - 2026)

Vireo Growth (VREOF) posted Cash & Current Investments of $153.2 million for Q1 2026, up 7.28% sequentially from $142.8 million in Q4 2025, and up 74.19% YoY from $88.0 million in Q1 2025.

Vireo Growth (VREOF) Cash & Current Investments (2020 - 2026) Analysis & Trends

Vireo Growth has reported Cash & Current Investments for 7 years, with the latest figure at $153.2 million in Q1 2026.

  • Quarterly Cash & Current Investments rose 74.19% year-over-year to $153.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $153.2 million (up 74.19% YoY) and the FY2025 annual result came in at $142.8 million, up 52.12% from the prior year.
  • Cash & Current Investments advanced to $153.2 million in Q1 2026 per VREOF's latest filing, from $142.8 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $153.2 million in Q1 2026 and troughed at $7.3 million in Q3 2024.
  • A 5-year average of $49.6 million and a median of $17.0 million in 2022 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2022 and 2025: Cash & Current Investments sank 78.79% in 2022, then soared 1528.49% in 2025.
  • Over 5 years, Cash & Current Investments stood at $15.1 million in 2022, then advanced by 18.17% to $17.9 million in 2023, then soared by 424.36% to $93.9 million in 2024, then jumped by 52.12% to $142.8 million in 2025, then gained by 7.28% to $153.2 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $153.2 million, $142.8 million, and $118.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 44.05 Bn 43.08 Bn - 963.33 Mn
2 Teva Pharmaceutical Industries 43.39 Bn 39.74 Bn 2.15 Bn 3.66 Bn
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn 1.68 Bn
4 Takeda Pharmaceutical 28.78 Bn 22.99 Bn 5.10 Bn 5.80 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn 2.66 Bn
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn 886.50 Mn
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn 389.80 Mn
8 Elanco Animal Health 11.92 Bn 11.39 Bn 798.00 Mn 530.00 Mn
9 Dr Reddys Laboratories 10.16 Bn 9.99 Bn - 164.00 Mn
10 Vireo Growth 491.44 Mn 349.14 Mn 95.30 Mn 142.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 153.20 Mn
Dec 31, 2025 142.80 Mn
Sep 30, 2025 118.55 Mn
Jun 30, 2025 100.41 Mn
Mar 31, 2025 87.95 Mn
Dec 31, 2024 93.87 Mn
Sep 30, 2024 7.28 Mn
Jun 30, 2024 11.23 Mn
Mar 31, 2024 12.60 Mn
Dec 31, 2023 17.90 Mn
Sep 30, 2023 13.30 Mn
Jun 30, 2023 11.35 Mn
Mar 31, 2023 10.35 Mn
Dec 31, 2022 15.15 Mn
Sep 30, 2022 21.84 Mn
Jun 30, 2022 16.97 Mn
Mar 31, 2022 8.60 Mn
Dec 31, 2021 15.16 Mn
Sep 30, 2021 11.78 Mn
Jun 30, 2021 20.83 Mn